GW PHARMACEUTICALS PLC Earnings Per Share, Basic and Diluted
GW PHARMACEUTICALS PLC reported Earnings Per Share, Basic and Diluted of -$0.08 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-26
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.08.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.03.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.02.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.02.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for fiscal 2020 was -$0.15.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for fiscal 2019 was -$0.02.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for fiscal 2018 was -$0.88.
- GW PHARMACEUTICALS PLC earnings per share, basic and diluted for fiscal 2017 was -$0.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.08 10-K · filed 2021-02-26 | -$0.15 10-K · filed 2021-02-26 | ||
| 2020-09-30 | -$0.03 10-K · filed 2021-02-26 | |||
| 2020-06-30 | -$0.02 10-K · filed 2021-02-26 | |||
| 2020-03-31 | -$0.02 10-K · filed 2021-02-26 | |||
| 2019-12-31 | -$0.02 10-K · filed 2021-02-26 | |||
| 2019-03-31 | -$0.14 10-Q · filed 2019-05-08 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.86 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.09 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2018-12-31 | -$0.20 10-K · filed 2021-02-26 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.67 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2018-09-30 | -$0.23 10-K · filed 2020-02-27 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.88 10-K · filed 2021-02-26 |
| 2018-06-30 | -$0.25 10-K · filed 2020-02-27 | -$0.45 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$0.65 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.83 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2018-03-31 | -$0.20 10-K · filed 2020-02-27 | -$0.40 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.58 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.75 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2017-12-31 | -$0.20 10-K · filed 2021-02-26 | -$0.37 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.69 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2017-09-30 | -$0.18 10-KT · filed 2019-02-28 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.49 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.56 10-K · filed 2020-02-27 |
| 2017-06-30 | -$0.17 10-KT · filed 2019-02-28 | -$0.31 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$0.38 derived: net income ÷ weighted average shares · filed 2019-02-28 | |
| 2017-03-31 | -$0.14 10-KT · filed 2019-02-28 | -$0.21 derived: net income ÷ weighted average shares · filed 2019-02-28 | ||
| 2016-12-31 | -$0.07 10-KT · filed 2019-02-28 | |||
| 2016-09-30 | -$0.34 10-KT · filed 2019-02-28 |